{
  "ticker": "VRTX",
  "last_updated": "2025-04-15T15:30:14.989776",
  "retention_years": 3,
  "count": 453,
  "transactions": [
    {
      "id": 118572,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-10-17",
      "transaction_shares": "5651",
      "transaction_price": "373.25",
      "transaction_type": "S",
      "shares_after_transaction": "40603"
    },
    {
      "id": 118593,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2023-10-17",
      "transaction_shares": "243",
      "transaction_price": "375.00",
      "transaction_type": "S",
      "shares_after_transaction": "3901"
    },
    {
      "id": 118568,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-10-16",
      "transaction_shares": "12962",
      "transaction_price": "374.00",
      "transaction_type": "S",
      "shares_after_transaction": "22425"
    },
    {
      "id": 118565,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2023-10-06",
      "transaction_shares": "242",
      "transaction_price": "360.00",
      "transaction_type": "S",
      "shares_after_transaction": "4144"
    },
    {
      "id": 118531,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lagarde Michel",
      "reporting_owner_cik": "0001518973",
      "reporting_owner_position": null,
      "transaction_date": "2023-10-05",
      "transaction_shares": "1132",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "1132"
    },
    {
      "id": 118535,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-10-03",
      "transaction_shares": "5651",
      "transaction_price": "345.28",
      "transaction_type": "S",
      "shares_after_transaction": "46254"
    },
    {
      "id": 118549,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2023-09-29",
      "transaction_shares": "408",
      "transaction_price": "350.72",
      "transaction_type": "F",
      "shares_after_transaction": "11179"
    },
    {
      "id": 118602,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-09-19",
      "transaction_shares": "5651",
      "transaction_price": "351.00",
      "transaction_type": "S",
      "shares_after_transaction": "51905"
    },
    {
      "id": 118654,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-09-05",
      "transaction_shares": "5651",
      "transaction_price": "352.66",
      "transaction_type": "S",
      "shares_after_transaction": "57556"
    },
    {
      "id": 118650,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-08-23",
      "transaction_shares": "2500",
      "transaction_price": "355.00",
      "transaction_type": "S",
      "shares_after_transaction": "48637"
    },
    {
      "id": 118590,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kearney Terrence C",
      "reporting_owner_cik": "0001289098",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-10",
      "transaction_shares": "10000",
      "transaction_price": "127.54",
      "transaction_type": "M",
      "shares_after_transaction": "16536"
    },
    {
      "id": 118610,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-08-10",
      "transaction_shares": "5750",
      "transaction_price": "345.79",
      "transaction_type": "S",
      "shares_after_transaction": "51137"
    },
    {
      "id": 118678,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP, Chief Patient Officer",
      "transaction_date": "2023-08-10",
      "transaction_shares": "10031",
      "transaction_price": "350.00",
      "transaction_type": "S",
      "shares_after_transaction": "58814"
    },
    {
      "id": 118592,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-09",
      "transaction_shares": "242",
      "transaction_price": "345.51",
      "transaction_type": "S",
      "shares_after_transaction": "4386"
    },
    {
      "id": 118620,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-08-09",
      "transaction_shares": "63",
      "transaction_price": "345.51",
      "transaction_type": "S",
      "shares_after_transaction": "32038"
    },
    {
      "id": 76603,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-07-17",
      "transaction_shares": "7828",
      "transaction_price": "355.00",
      "transaction_type": "S",
      "shares_after_transaction": "118906"
    },
    {
      "id": 76627,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-17",
      "transaction_shares": "11250",
      "transaction_price": "127.54",
      "transaction_type": "M",
      "shares_after_transaction": "51250"
    },
    {
      "id": 118641,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-07-17",
      "transaction_shares": "7828",
      "transaction_price": "355.00",
      "transaction_type": "S",
      "shares_after_transaction": "118906"
    },
    {
      "id": 118668,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-17",
      "transaction_shares": "11250",
      "transaction_price": "127.54",
      "transaction_type": "M",
      "shares_after_transaction": "51250"
    },
    {
      "id": 76540,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-06-15",
      "transaction_shares": "8603",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "65159"
    },
    {
      "id": 118570,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-06-15",
      "transaction_shares": "8603",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "65159"
    },
    {
      "id": 76558,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-05-30",
      "transaction_shares": "82",
      "transaction_price": "329.82",
      "transaction_type": "S",
      "shares_after_transaction": "56556"
    },
    {
      "id": 76594,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2023-05-30",
      "transaction_shares": "289",
      "transaction_price": "329.82",
      "transaction_type": "S",
      "shares_after_transaction": "6838"
    },
    {
      "id": 118589,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-05-30",
      "transaction_shares": "82",
      "transaction_price": "329.82",
      "transaction_type": "S",
      "shares_after_transaction": "56556"
    },
    {
      "id": 118631,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2023-05-30",
      "transaction_shares": "289",
      "transaction_price": "329.82",
      "transaction_type": "S",
      "shares_after_transaction": "6838"
    },
    {
      "id": 76525,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-05-05",
      "transaction_shares": "708",
      "transaction_price": "349.38",
      "transaction_type": "S",
      "shares_after_transaction": "36683"
    },
    {
      "id": 76535,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-05-05",
      "transaction_shares": "422",
      "transaction_price": "350.03",
      "transaction_type": "S",
      "shares_after_transaction": "34888"
    },
    {
      "id": 118553,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-05-05",
      "transaction_shares": "708",
      "transaction_price": "349.38",
      "transaction_type": "S",
      "shares_after_transaction": "36683"
    },
    {
      "id": 118563,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-05-05",
      "transaction_shares": "422",
      "transaction_price": "350.03",
      "transaction_type": "S",
      "shares_after_transaction": "34888"
    },
    {
      "id": 76563,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-05-02",
      "transaction_shares": "4645",
      "transaction_price": "349.48",
      "transaction_type": "S",
      "shares_after_transaction": "43704"
    },
    {
      "id": 76611,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-05-02",
      "transaction_shares": "1411",
      "transaction_price": "350.32",
      "transaction_type": "S",
      "shares_after_transaction": "38302"
    },
    {
      "id": 118597,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-05-02",
      "transaction_shares": "4645",
      "transaction_price": "349.48",
      "transaction_type": "S",
      "shares_after_transaction": "43704"
    },
    {
      "id": 118649,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-05-02",
      "transaction_shares": "1411",
      "transaction_price": "350.32",
      "transaction_type": "S",
      "shares_after_transaction": "38302"
    },
    {
      "id": 76529,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Garber Alan M",
      "reporting_owner_cik": "0001312907",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "584",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6474"
    },
    {
      "id": 76547,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1168",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "5208"
    },
    {
      "id": 76579,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1168",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "2726"
    },
    {
      "id": 76584,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1168",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "5318"
    },
    {
      "id": 76623,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1449",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "1435"
    },
    {
      "id": 118557,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Garber Alan M",
      "reporting_owner_cik": "0001312907",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "584",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6474"
    },
    {
      "id": 118578,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1168",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "5208"
    },
    {
      "id": 118615,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1168",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "2726"
    },
    {
      "id": 118621,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1168",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "5318"
    },
    {
      "id": 118664,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1449",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "1435"
    },
    {
      "id": 76639,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-04-27",
      "transaction_shares": "1611",
      "transaction_price": "338.69",
      "transaction_type": "S",
      "shares_after_transaction": "128358"
    },
    {
      "id": 118681,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-04-27",
      "transaction_shares": "1611",
      "transaction_price": "338.69",
      "transaction_type": "S",
      "shares_after_transaction": "128358"
    },
    {
      "id": 42998,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-04-12",
      "transaction_shares": "874",
      "transaction_price": "325.70",
      "transaction_type": "S",
      "shares_after_transaction": "46406"
    },
    {
      "id": 43024,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-12",
      "transaction_shares": "21300",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "62510"
    },
    {
      "id": 76585,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-04-12",
      "transaction_shares": "874",
      "transaction_price": "325.70",
      "transaction_type": "S",
      "shares_after_transaction": "46406"
    },
    {
      "id": 76615,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-12",
      "transaction_shares": "21300",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "62510"
    },
    {
      "id": 118622,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-04-12",
      "transaction_shares": "874",
      "transaction_price": "325.70",
      "transaction_type": "S",
      "shares_after_transaction": "46406"
    },
    {
      "id": 118655,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-12",
      "transaction_shares": "21300",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "62510"
    },
    {
      "id": 43027,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-04-04",
      "transaction_shares": "211",
      "transaction_price": "314.22",
      "transaction_type": "S",
      "shares_after_transaction": "47591"
    },
    {
      "id": 76618,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-04-04",
      "transaction_shares": "211",
      "transaction_price": "314.22",
      "transaction_type": "S",
      "shares_after_transaction": "47591"
    },
    {
      "id": 118658,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-04-04",
      "transaction_shares": "211",
      "transaction_price": "314.22",
      "transaction_type": "S",
      "shares_after_transaction": "47591"
    },
    {
      "id": 42964,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2023-03-31",
      "transaction_shares": "176",
      "transaction_price": "313.74",
      "transaction_type": "F",
      "shares_after_transaction": "7127"
    },
    {
      "id": 42968,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-03-31",
      "transaction_shares": "1466",
      "transaction_price": "313.74",
      "transaction_type": "F",
      "shares_after_transaction": "47802"
    },
    {
      "id": 76544,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2023-03-31",
      "transaction_shares": "176",
      "transaction_price": "313.74",
      "transaction_type": "F",
      "shares_after_transaction": "7127"
    },
    {
      "id": 76549,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-03-31",
      "transaction_shares": "1466",
      "transaction_price": "313.74",
      "transaction_type": "F",
      "shares_after_transaction": "47802"
    },
    {
      "id": 118575,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2023-03-31",
      "transaction_shares": "176",
      "transaction_price": "313.74",
      "transaction_type": "F",
      "shares_after_transaction": "7127"
    },
    {
      "id": 118580,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-03-31",
      "transaction_shares": "1466",
      "transaction_price": "313.74",
      "transaction_type": "F",
      "shares_after_transaction": "47802"
    },
    {
      "id": 43017,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-03-24",
      "transaction_shares": "1768",
      "transaction_price": "305.38",
      "transaction_type": "S",
      "shares_after_transaction": "49611"
    },
    {
      "id": 76607,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-03-24",
      "transaction_shares": "1768",
      "transaction_price": "305.38",
      "transaction_type": "S",
      "shares_after_transaction": "49611"
    },
    {
      "id": 118645,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-03-24",
      "transaction_shares": "1768",
      "transaction_price": "305.38",
      "transaction_type": "S",
      "shares_after_transaction": "49611"
    },
    {
      "id": 42932,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-03-17",
      "transaction_shares": "360",
      "transaction_price": "294.52",
      "transaction_type": "S",
      "shares_after_transaction": "53019"
    },
    {
      "id": 76506,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-03-17",
      "transaction_shares": "360",
      "transaction_price": "294.52",
      "transaction_type": "S",
      "shares_after_transaction": "53019"
    },
    {
      "id": 118532,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-03-17",
      "transaction_shares": "360",
      "transaction_price": "294.52",
      "transaction_type": "S",
      "shares_after_transaction": "53019"
    },
    {
      "id": 42957,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-03-16",
      "transaction_shares": "2482",
      "transaction_price": "300.54",
      "transaction_type": "S",
      "shares_after_transaction": "49532"
    },
    {
      "id": 76534,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-03-16",
      "transaction_shares": "2482",
      "transaction_price": "300.54",
      "transaction_type": "S",
      "shares_after_transaction": "49532"
    },
    {
      "id": 118562,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-03-16",
      "transaction_shares": "2482",
      "transaction_price": "300.54",
      "transaction_type": "S",
      "shares_after_transaction": "49532"
    },
    {
      "id": 42946,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-03-10",
      "transaction_shares": "361",
      "transaction_price": "286.64",
      "transaction_type": "S",
      "shares_after_transaction": "57772"
    },
    {
      "id": 76521,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-03-10",
      "transaction_shares": "361",
      "transaction_price": "286.64",
      "transaction_type": "S",
      "shares_after_transaction": "57772"
    },
    {
      "id": 118548,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-03-10",
      "transaction_shares": "361",
      "transaction_price": "286.64",
      "transaction_type": "S",
      "shares_after_transaction": "57772"
    },
    {
      "id": 42941,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-02-24",
      "transaction_shares": "3970",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "52014"
    },
    {
      "id": 42943,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP, Chief Patient Officer",
      "transaction_date": "2023-02-24",
      "transaction_shares": "2468",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "66518"
    },
    {
      "id": 42982,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-02-24",
      "transaction_shares": "13730",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "48349"
    },
    {
      "id": 42989,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2023-02-24",
      "transaction_shares": "502",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "8510"
    },
    {
      "id": 42993,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-24",
      "transaction_shares": "3970",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "36276"
    },
    {
      "id": 42999,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-02-24",
      "transaction_shares": "3308",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "57159"
    },
    {
      "id": 43016,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-02-24",
      "transaction_shares": "3308",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "63207"
    },
    {
      "id": 43033,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-24",
      "transaction_shares": "4714",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "61590"
    },
    {
      "id": 43041,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-02-24",
      "transaction_shares": "9386",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "129969"
    },
    {
      "id": 43042,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-02-24",
      "transaction_shares": "3308",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "58133"
    },
    {
      "id": 76516,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-02-24",
      "transaction_shares": "3970",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "52014"
    },
    {
      "id": 76518,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP, Chief Patient Officer",
      "transaction_date": "2023-02-24",
      "transaction_shares": "2468",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "66518"
    },
    {
      "id": 76566,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-02-24",
      "transaction_shares": "13730",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "48349"
    },
    {
      "id": 76574,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2023-02-24",
      "transaction_shares": "502",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "8510"
    },
    {
      "id": 76578,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-24",
      "transaction_shares": "3970",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "36276"
    },
    {
      "id": 76586,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-02-24",
      "transaction_shares": "3308",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "57159"
    },
    {
      "id": 76606,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-02-24",
      "transaction_shares": "3308",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "63207"
    },
    {
      "id": 76625,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-24",
      "transaction_shares": "4714",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "61590"
    },
    {
      "id": 76634,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-02-24",
      "transaction_shares": "9386",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "129969"
    },
    {
      "id": 76635,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-02-24",
      "transaction_shares": "3308",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "58133"
    },
    {
      "id": 118543,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-02-24",
      "transaction_shares": "3970",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "52014"
    },
    {
      "id": 118545,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP, Chief Patient Officer",
      "transaction_date": "2023-02-24",
      "transaction_shares": "2468",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "66518"
    },
    {
      "id": 118600,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-02-24",
      "transaction_shares": "13730",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "48349"
    },
    {
      "id": 118609,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2023-02-24",
      "transaction_shares": "502",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "8510"
    },
    {
      "id": 118614,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-24",
      "transaction_shares": "3970",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "36276"
    },
    {
      "id": 118623,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-02-24",
      "transaction_shares": "3308",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "57159"
    },
    {
      "id": 118644,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-02-24",
      "transaction_shares": "3308",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "63207"
    },
    {
      "id": 118666,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-24",
      "transaction_shares": "4714",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "61590"
    },
    {
      "id": 118675,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-02-24",
      "transaction_shares": "9386",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "129969"
    },
    {
      "id": 118676,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-02-24",
      "transaction_shares": "3308",
      "transaction_price": "289.12",
      "transaction_type": "F",
      "shares_after_transaction": "58133"
    },
    {
      "id": 42940,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "129",
      "transaction_price": "291.84",
      "transaction_type": "S",
      "shares_after_transaction": "68576"
    },
    {
      "id": 76515,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "129",
      "transaction_price": "291.84",
      "transaction_type": "S",
      "shares_after_transaction": "68576"
    },
    {
      "id": 118542,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-22",
      "transaction_shares": "129",
      "transaction_price": "291.84",
      "transaction_type": "S",
      "shares_after_transaction": "68576"
    },
    {
      "id": 42962,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-02-17",
      "transaction_shares": "9359",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "139355"
    },
    {
      "id": 42971,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-02-17",
      "transaction_shares": "4498",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "60947"
    },
    {
      "id": 42981,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-02-17",
      "transaction_shares": "3750",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "55984"
    },
    {
      "id": 42990,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-17",
      "transaction_shares": "4498",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "71107"
    },
    {
      "id": 42992,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-02-17",
      "transaction_shares": "3750",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "66515"
    },
    {
      "id": 43021,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-17",
      "transaction_shares": "3750",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "44248"
    },
    {
      "id": 43046,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-02-17",
      "transaction_shares": "3750",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "61441"
    },
    {
      "id": 43047,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP, Chief Patient Officer",
      "transaction_date": "2023-02-17",
      "transaction_shares": "3498",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "68986"
    },
    {
      "id": 76541,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-02-17",
      "transaction_shares": "9359",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "139355"
    },
    {
      "id": 76552,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-02-17",
      "transaction_shares": "4498",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "60947"
    },
    {
      "id": 76565,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-02-17",
      "transaction_shares": "3750",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "55984"
    },
    {
      "id": 76575,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-17",
      "transaction_shares": "4498",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "71107"
    },
    {
      "id": 76577,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-02-17",
      "transaction_shares": "3750",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "66515"
    },
    {
      "id": 76612,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-17",
      "transaction_shares": "3750",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "44248"
    },
    {
      "id": 76640,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-02-17",
      "transaction_shares": "3750",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "61441"
    },
    {
      "id": 76641,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP, Chief Patient Officer",
      "transaction_date": "2023-02-17",
      "transaction_shares": "3498",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "68986"
    },
    {
      "id": 118571,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-02-17",
      "transaction_shares": "9359",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "139355"
    },
    {
      "id": 118583,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-02-17",
      "transaction_shares": "4498",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "60947"
    },
    {
      "id": 118599,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-02-17",
      "transaction_shares": "3750",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "55984"
    },
    {
      "id": 118611,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-17",
      "transaction_shares": "4498",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "71107"
    },
    {
      "id": 118613,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-02-17",
      "transaction_shares": "3750",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "66515"
    },
    {
      "id": 118651,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-17",
      "transaction_shares": "3750",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "44248"
    },
    {
      "id": 118682,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-02-17",
      "transaction_shares": "3750",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "61441"
    },
    {
      "id": 118683,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP, Chief Patient Officer",
      "transaction_date": "2023-02-17",
      "transaction_shares": "3498",
      "transaction_price": "292.85",
      "transaction_type": "F",
      "shares_after_transaction": "68986"
    },
    {
      "id": 42945,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-14",
      "transaction_shares": "800",
      "transaction_price": "295.84",
      "transaction_type": "S",
      "shares_after_transaction": "81203"
    },
    {
      "id": 42955,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-14",
      "transaction_shares": "800",
      "transaction_price": "295.79",
      "transaction_type": "S",
      "shares_after_transaction": "53596"
    },
    {
      "id": 42975,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-02-14",
      "transaction_shares": "1902",
      "transaction_price": "300.29",
      "transaction_type": "S",
      "shares_after_transaction": "60013"
    },
    {
      "id": 43015,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-02-14",
      "transaction_shares": "71",
      "transaction_price": "295.89",
      "transaction_type": "S",
      "shares_after_transaction": "65694"
    },
    {
      "id": 76520,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-14",
      "transaction_shares": "800",
      "transaction_price": "295.84",
      "transaction_type": "S",
      "shares_after_transaction": "81203"
    },
    {
      "id": 76532,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-14",
      "transaction_shares": "800",
      "transaction_price": "295.79",
      "transaction_type": "S",
      "shares_after_transaction": "53596"
    },
    {
      "id": 76557,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-02-14",
      "transaction_shares": "1902",
      "transaction_price": "300.29",
      "transaction_type": "S",
      "shares_after_transaction": "60013"
    },
    {
      "id": 76605,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-02-14",
      "transaction_shares": "71",
      "transaction_price": "295.89",
      "transaction_type": "S",
      "shares_after_transaction": "65694"
    },
    {
      "id": 118547,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-14",
      "transaction_shares": "800",
      "transaction_price": "295.84",
      "transaction_type": "S",
      "shares_after_transaction": "81203"
    },
    {
      "id": 118560,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-14",
      "transaction_shares": "800",
      "transaction_price": "295.79",
      "transaction_type": "S",
      "shares_after_transaction": "53596"
    },
    {
      "id": 118588,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-02-14",
      "transaction_shares": "1902",
      "transaction_price": "300.29",
      "transaction_type": "S",
      "shares_after_transaction": "60013"
    },
    {
      "id": 118643,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-02-14",
      "transaction_shares": "71",
      "transaction_price": "295.89",
      "transaction_type": "S",
      "shares_after_transaction": "65694"
    },
    {
      "id": 42965,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-02-13",
      "transaction_shares": "13344",
      "transaction_price": "298.26",
      "transaction_type": "F",
      "shares_after_transaction": "62079"
    },
    {
      "id": 76545,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-02-13",
      "transaction_shares": "13344",
      "transaction_price": "298.26",
      "transaction_type": "F",
      "shares_after_transaction": "62079"
    },
    {
      "id": 118576,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-02-13",
      "transaction_shares": "13344",
      "transaction_price": "298.26",
      "transaction_type": "F",
      "shares_after_transaction": "62079"
    },
    {
      "id": 42947,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-02-10",
      "transaction_shares": "902",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "66368"
    },
    {
      "id": 42956,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-02-10",
      "transaction_shares": "2707",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "70183"
    },
    {
      "id": 42970,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-10",
      "transaction_shares": "3461",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "65184"
    },
    {
      "id": 42976,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-02-10",
      "transaction_shares": "3372",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "154704"
    },
    {
      "id": 42984,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-02-10",
      "transaction_shares": "2707",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "75257"
    },
    {
      "id": 43003,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-02-10",
      "transaction_shares": "1377",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "69035"
    },
    {
      "id": 43023,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP, Chief Patient Officer",
      "transaction_date": "2023-02-10",
      "transaction_shares": "2611",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "77141"
    },
    {
      "id": 43031,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-10",
      "transaction_shares": "3372",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "92880"
    },
    {
      "id": 76522,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-02-10",
      "transaction_shares": "902",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "66368"
    },
    {
      "id": 76533,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-02-10",
      "transaction_shares": "2707",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "70183"
    },
    {
      "id": 76551,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-10",
      "transaction_shares": "3461",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "65184"
    },
    {
      "id": 76559,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-02-10",
      "transaction_shares": "3372",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "154704"
    },
    {
      "id": 76569,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-02-10",
      "transaction_shares": "2707",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "75257"
    },
    {
      "id": 76591,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-02-10",
      "transaction_shares": "1377",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "69035"
    },
    {
      "id": 76614,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP, Chief Patient Officer",
      "transaction_date": "2023-02-10",
      "transaction_shares": "2611",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "77141"
    },
    {
      "id": 76622,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-10",
      "transaction_shares": "3372",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "92880"
    },
    {
      "id": 118550,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-02-10",
      "transaction_shares": "902",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "66368"
    },
    {
      "id": 118561,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-02-10",
      "transaction_shares": "2707",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "70183"
    },
    {
      "id": 118582,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-10",
      "transaction_shares": "3461",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "65184"
    },
    {
      "id": 118591,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-02-10",
      "transaction_shares": "3372",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "154704"
    },
    {
      "id": 118604,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-02-10",
      "transaction_shares": "2707",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "75257"
    },
    {
      "id": 118628,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-02-10",
      "transaction_shares": "1377",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "69035"
    },
    {
      "id": 118653,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP, Chief Patient Officer",
      "transaction_date": "2023-02-10",
      "transaction_shares": "2611",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "77141"
    },
    {
      "id": 118663,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-10",
      "transaction_shares": "3372",
      "transaction_price": "294.33",
      "transaction_type": "F",
      "shares_after_transaction": "92880"
    },
    {
      "id": 42972,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-06",
      "transaction_shares": "1304",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "69949"
    },
    {
      "id": 76553,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-06",
      "transaction_shares": "1304",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "69949"
    },
    {
      "id": 118584,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-06",
      "transaction_shares": "1304",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "69949"
    },
    {
      "id": 42929,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-01",
      "transaction_shares": "12388",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "70419"
    },
    {
      "id": 42930,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2023-02-01",
      "transaction_shares": "6293",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "11587"
    },
    {
      "id": 42949,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-02-01",
      "transaction_shares": "9092",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "47090"
    },
    {
      "id": 42954,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-01",
      "transaction_shares": "12388",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "48465"
    },
    {
      "id": 42961,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-02-01",
      "transaction_shares": "31462",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "33885"
    },
    {
      "id": 42969,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2023-02-01",
      "transaction_shares": "2566",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6062"
    },
    {
      "id": 42979,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-02-01",
      "transaction_shares": "12388",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "101986"
    },
    {
      "id": 43019,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-02-01",
      "transaction_shares": "10324",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "53188"
    },
    {
      "id": 43029,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-02-01",
      "transaction_shares": "10324",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "59836"
    },
    {
      "id": 43038,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-02-01",
      "transaction_shares": "6194",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "52284"
    },
    {
      "id": 76503,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-01",
      "transaction_shares": "12388",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "70419"
    },
    {
      "id": 76504,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2023-02-01",
      "transaction_shares": "6293",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "11587"
    },
    {
      "id": 76524,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-02-01",
      "transaction_shares": "9092",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "47090"
    },
    {
      "id": 76531,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-01",
      "transaction_shares": "12388",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "48465"
    },
    {
      "id": 76539,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-02-01",
      "transaction_shares": "31462",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "33885"
    },
    {
      "id": 76550,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2023-02-01",
      "transaction_shares": "2566",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6062"
    },
    {
      "id": 76562,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-02-01",
      "transaction_shares": "12388",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "101986"
    },
    {
      "id": 76609,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-02-01",
      "transaction_shares": "10324",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "53188"
    },
    {
      "id": 76620,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-02-01",
      "transaction_shares": "10324",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "59836"
    },
    {
      "id": 76631,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-02-01",
      "transaction_shares": "6194",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "52284"
    },
    {
      "id": 118528,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-02-01",
      "transaction_shares": "12388",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "70419"
    },
    {
      "id": 118529,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2023-02-01",
      "transaction_shares": "6293",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "11587"
    },
    {
      "id": 118552,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-02-01",
      "transaction_shares": "9092",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "47090"
    },
    {
      "id": 118559,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-02-01",
      "transaction_shares": "12388",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "48465"
    },
    {
      "id": 118569,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-02-01",
      "transaction_shares": "31462",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "33885"
    },
    {
      "id": 118581,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2023-02-01",
      "transaction_shares": "2566",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6062"
    },
    {
      "id": 118596,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-02-01",
      "transaction_shares": "12388",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "101986"
    },
    {
      "id": 118647,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-02-01",
      "transaction_shares": "10324",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "53188"
    },
    {
      "id": 118660,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-02-01",
      "transaction_shares": "10324",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "59836"
    },
    {
      "id": 118672,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2023-02-01",
      "transaction_shares": "6194",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "52284"
    },
    {
      "id": 42944,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-31",
      "transaction_shares": "1200",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "42410"
    },
    {
      "id": 43032,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-01-31",
      "transaction_shares": "106",
      "transaction_price": "325.00",
      "transaction_type": "S",
      "shares_after_transaction": "37998"
    },
    {
      "id": 76519,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-31",
      "transaction_shares": "1200",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "42410"
    },
    {
      "id": 76624,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-01-31",
      "transaction_shares": "106",
      "transaction_price": "325.00",
      "transaction_type": "S",
      "shares_after_transaction": "37998"
    },
    {
      "id": 118546,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-31",
      "transaction_shares": "1200",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "42410"
    },
    {
      "id": 118665,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-01-31",
      "transaction_shares": "106",
      "transaction_price": "325.00",
      "transaction_type": "S",
      "shares_after_transaction": "37998"
    },
    {
      "id": 43028,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-30",
      "transaction_shares": "1376",
      "transaction_price": "320.08",
      "transaction_type": "S",
      "shares_after_transaction": "5474"
    },
    {
      "id": 76619,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-30",
      "transaction_shares": "1376",
      "transaction_price": "320.08",
      "transaction_type": "S",
      "shares_after_transaction": "5474"
    },
    {
      "id": 118659,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-30",
      "transaction_shares": "1376",
      "transaction_price": "320.08",
      "transaction_type": "S",
      "shares_after_transaction": "5474"
    },
    {
      "id": 43039,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-27",
      "transaction_shares": "1429",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "3304"
    },
    {
      "id": 76632,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-27",
      "transaction_shares": "1429",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "3304"
    },
    {
      "id": 118673,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-27",
      "transaction_shares": "1429",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "3304"
    },
    {
      "id": 42966,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-01-25",
      "transaction_shares": "10000",
      "transaction_price": "315.05",
      "transaction_type": "S",
      "shares_after_transaction": "89598"
    },
    {
      "id": 43030,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-25",
      "transaction_shares": "4000",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "5875"
    },
    {
      "id": 76546,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-01-25",
      "transaction_shares": "10000",
      "transaction_price": "315.05",
      "transaction_type": "S",
      "shares_after_transaction": "89598"
    },
    {
      "id": 76621,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-25",
      "transaction_shares": "4000",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "5875"
    },
    {
      "id": 118577,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-01-25",
      "transaction_shares": "10000",
      "transaction_price": "315.05",
      "transaction_type": "S",
      "shares_after_transaction": "89598"
    },
    {
      "id": 118662,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-25",
      "transaction_shares": "4000",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "5875"
    },
    {
      "id": 43004,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-23",
      "transaction_shares": "2129",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "4004"
    },
    {
      "id": 76592,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-23",
      "transaction_shares": "2129",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "4004"
    },
    {
      "id": 118629,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-23",
      "transaction_shares": "2129",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "4004"
    },
    {
      "id": 43002,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-17",
      "transaction_shares": "4000",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "5875"
    },
    {
      "id": 76589,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-17",
      "transaction_shares": "4000",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "5875"
    },
    {
      "id": 118626,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-17",
      "transaction_shares": "4000",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "5875"
    },
    {
      "id": 22113,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-12-06",
      "transaction_shares": "12753",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "58031"
    },
    {
      "id": 42995,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-12-06",
      "transaction_shares": "12753",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "58031"
    },
    {
      "id": 76581,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-12-06",
      "transaction_shares": "12753",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "58031"
    },
    {
      "id": 118617,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-12-06",
      "transaction_shares": "12753",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "58031"
    },
    {
      "id": 22118,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-11-15",
      "transaction_shares": "34",
      "transaction_price": "308.61",
      "transaction_type": "S",
      "shares_after_transaction": "36077"
    },
    {
      "id": 43006,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-11-15",
      "transaction_shares": "34",
      "transaction_price": "308.61",
      "transaction_type": "S",
      "shares_after_transaction": "36077"
    },
    {
      "id": 76595,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-11-15",
      "transaction_shares": "34",
      "transaction_price": "308.61",
      "transaction_type": "S",
      "shares_after_transaction": "36077"
    },
    {
      "id": 118632,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-11-15",
      "transaction_shares": "34",
      "transaction_price": "308.61",
      "transaction_type": "S",
      "shares_after_transaction": "36077"
    },
    {
      "id": 22121,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-11-07",
      "transaction_shares": "1303",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "37380"
    },
    {
      "id": 43010,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-11-07",
      "transaction_shares": "1303",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "37380"
    },
    {
      "id": 76599,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-11-07",
      "transaction_shares": "1303",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "37380"
    },
    {
      "id": 118636,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-11-07",
      "transaction_shares": "1303",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "37380"
    },
    {
      "id": 22097,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-11-01",
      "transaction_shares": "768",
      "transaction_price": "312.84",
      "transaction_type": "F",
      "shares_after_transaction": "38424"
    },
    {
      "id": 42953,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-11-01",
      "transaction_shares": "768",
      "transaction_price": "312.84",
      "transaction_type": "F",
      "shares_after_transaction": "38424"
    },
    {
      "id": 76530,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-11-01",
      "transaction_shares": "768",
      "transaction_price": "312.84",
      "transaction_type": "F",
      "shares_after_transaction": "38424"
    },
    {
      "id": 118558,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-11-01",
      "transaction_shares": "768",
      "transaction_price": "312.84",
      "transaction_type": "F",
      "shares_after_transaction": "38424"
    },
    {
      "id": 22125,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-24",
      "transaction_shares": "621",
      "transaction_price": "310.00",
      "transaction_type": "S",
      "shares_after_transaction": "4040"
    },
    {
      "id": 43018,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-24",
      "transaction_shares": "621",
      "transaction_price": "310.00",
      "transaction_type": "S",
      "shares_after_transaction": "4040"
    },
    {
      "id": 76608,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-24",
      "transaction_shares": "621",
      "transaction_price": "310.00",
      "transaction_type": "S",
      "shares_after_transaction": "4040"
    },
    {
      "id": 118646,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-24",
      "transaction_shares": "621",
      "transaction_price": "310.00",
      "transaction_type": "S",
      "shares_after_transaction": "4040"
    },
    {
      "id": 22131,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-10-18",
      "transaction_shares": "1503",
      "transaction_price": "300.02",
      "transaction_type": "S",
      "shares_after_transaction": "39480"
    },
    {
      "id": 43035,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-10-18",
      "transaction_shares": "1503",
      "transaction_price": "300.02",
      "transaction_type": "S",
      "shares_after_transaction": "39480"
    },
    {
      "id": 76628,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-10-18",
      "transaction_shares": "1503",
      "transaction_price": "300.02",
      "transaction_type": "S",
      "shares_after_transaction": "39480"
    },
    {
      "id": 118669,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-10-18",
      "transaction_shares": "1503",
      "transaction_price": "300.02",
      "transaction_type": "S",
      "shares_after_transaction": "39480"
    },
    {
      "id": 8262,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2022-09-19",
      "transaction_shares": "5294",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "5294"
    },
    {
      "id": 22124,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2022-09-19",
      "transaction_shares": "5294",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "5294"
    },
    {
      "id": 43014,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2022-09-19",
      "transaction_shares": "5294",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "5294"
    },
    {
      "id": 76604,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2022-09-19",
      "transaction_shares": "5294",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "5294"
    },
    {
      "id": 118642,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2022-09-19",
      "transaction_shares": "5294",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "5294"
    },
    {
      "id": 8236,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "6571",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "67451"
    },
    {
      "id": 8260,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-15",
      "transaction_shares": "206",
      "transaction_price": "300.26",
      "transaction_type": "S",
      "shares_after_transaction": "13146"
    },
    {
      "id": 8268,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2022-08-15",
      "transaction_shares": "11689",
      "transaction_price": "305.06",
      "transaction_type": "S",
      "shares_after_transaction": "99598"
    },
    {
      "id": 22091,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "6571",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "67451"
    },
    {
      "id": 22120,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-15",
      "transaction_shares": "206",
      "transaction_price": "300.26",
      "transaction_type": "S",
      "shares_after_transaction": "13146"
    },
    {
      "id": 22132,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2022-08-15",
      "transaction_shares": "11689",
      "transaction_price": "305.06",
      "transaction_type": "S",
      "shares_after_transaction": "99598"
    },
    {
      "id": 42939,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "6571",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "67451"
    },
    {
      "id": 43009,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-15",
      "transaction_shares": "206",
      "transaction_price": "300.26",
      "transaction_type": "S",
      "shares_after_transaction": "13146"
    },
    {
      "id": 43036,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2022-08-15",
      "transaction_shares": "11689",
      "transaction_price": "305.06",
      "transaction_type": "S",
      "shares_after_transaction": "99598"
    },
    {
      "id": 76514,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "6571",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "67451"
    },
    {
      "id": 76598,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-15",
      "transaction_shares": "206",
      "transaction_price": "300.26",
      "transaction_type": "S",
      "shares_after_transaction": "13146"
    },
    {
      "id": 76629,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2022-08-15",
      "transaction_shares": "11689",
      "transaction_price": "305.06",
      "transaction_type": "S",
      "shares_after_transaction": "99598"
    },
    {
      "id": 118541,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "6571",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "67451"
    },
    {
      "id": 118635,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-15",
      "transaction_shares": "206",
      "transaction_price": "300.26",
      "transaction_type": "S",
      "shares_after_transaction": "13146"
    },
    {
      "id": 118670,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2022-08-15",
      "transaction_shares": "11689",
      "transaction_price": "305.06",
      "transaction_type": "S",
      "shares_after_transaction": "99598"
    },
    {
      "id": 8229,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-10",
      "transaction_shares": "36",
      "transaction_price": "300.32",
      "transaction_type": "S",
      "shares_after_transaction": "13352"
    },
    {
      "id": 8252,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-10",
      "transaction_shares": "64",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "61060"
    },
    {
      "id": 22084,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-10",
      "transaction_shares": "36",
      "transaction_price": "300.32",
      "transaction_type": "S",
      "shares_after_transaction": "13352"
    },
    {
      "id": 22109,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-10",
      "transaction_shares": "64",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "61060"
    },
    {
      "id": 42931,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-10",
      "transaction_shares": "36",
      "transaction_price": "300.32",
      "transaction_type": "S",
      "shares_after_transaction": "13352"
    },
    {
      "id": 42987,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-10",
      "transaction_shares": "64",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "61060"
    },
    {
      "id": 76505,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-10",
      "transaction_shares": "36",
      "transaction_price": "300.32",
      "transaction_type": "S",
      "shares_after_transaction": "13352"
    },
    {
      "id": 76572,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-10",
      "transaction_shares": "64",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "61060"
    },
    {
      "id": 118530,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-10",
      "transaction_shares": "36",
      "transaction_price": "300.32",
      "transaction_type": "S",
      "shares_after_transaction": "13352"
    },
    {
      "id": 118607,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-10",
      "transaction_shares": "64",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "61060"
    },
    {
      "id": 8245,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2022-08-09",
      "transaction_shares": "292",
      "transaction_price": "297.54",
      "transaction_type": "S",
      "shares_after_transaction": "47198"
    },
    {
      "id": 8251,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-09",
      "transaction_shares": "946",
      "transaction_price": "300.00",
      "transaction_type": "S",
      "shares_after_transaction": "13388"
    },
    {
      "id": 8266,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-09",
      "transaction_shares": "1926",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "66686"
    },
    {
      "id": 22102,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2022-08-09",
      "transaction_shares": "292",
      "transaction_price": "297.54",
      "transaction_type": "S",
      "shares_after_transaction": "47198"
    },
    {
      "id": 22108,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-09",
      "transaction_shares": "946",
      "transaction_price": "300.00",
      "transaction_type": "S",
      "shares_after_transaction": "13388"
    },
    {
      "id": 22129,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-09",
      "transaction_shares": "1926",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "66686"
    },
    {
      "id": 42973,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2022-08-09",
      "transaction_shares": "292",
      "transaction_price": "297.54",
      "transaction_type": "S",
      "shares_after_transaction": "47198"
    },
    {
      "id": 42986,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-09",
      "transaction_shares": "946",
      "transaction_price": "300.00",
      "transaction_type": "S",
      "shares_after_transaction": "13388"
    },
    {
      "id": 43026,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-09",
      "transaction_shares": "1926",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "66686"
    },
    {
      "id": 76554,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2022-08-09",
      "transaction_shares": "292",
      "transaction_price": "297.54",
      "transaction_type": "S",
      "shares_after_transaction": "47198"
    },
    {
      "id": 76571,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-09",
      "transaction_shares": "946",
      "transaction_price": "300.00",
      "transaction_type": "S",
      "shares_after_transaction": "13388"
    },
    {
      "id": 76617,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-09",
      "transaction_shares": "1926",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "66686"
    },
    {
      "id": 118585,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2022-08-09",
      "transaction_shares": "292",
      "transaction_price": "297.54",
      "transaction_type": "S",
      "shares_after_transaction": "47198"
    },
    {
      "id": 118606,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-09",
      "transaction_shares": "946",
      "transaction_price": "300.00",
      "transaction_type": "S",
      "shares_after_transaction": "13388"
    },
    {
      "id": 118657,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-09",
      "transaction_shares": "1926",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "66686"
    },
    {
      "id": 8242,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-08-08",
      "transaction_shares": "1304",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "37381"
    },
    {
      "id": 8261,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-08",
      "transaction_shares": "45",
      "transaction_price": "290.18",
      "transaction_type": "S",
      "shares_after_transaction": "5237"
    },
    {
      "id": 22098,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-08-08",
      "transaction_shares": "1304",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "37381"
    },
    {
      "id": 22122,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-08",
      "transaction_shares": "45",
      "transaction_price": "290.18",
      "transaction_type": "S",
      "shares_after_transaction": "5237"
    },
    {
      "id": 42959,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-08-08",
      "transaction_shares": "1304",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "37381"
    },
    {
      "id": 43012,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-08",
      "transaction_shares": "45",
      "transaction_price": "290.18",
      "transaction_type": "S",
      "shares_after_transaction": "5237"
    },
    {
      "id": 76537,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-08-08",
      "transaction_shares": "1304",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "37381"
    },
    {
      "id": 76601,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-08",
      "transaction_shares": "45",
      "transaction_price": "290.18",
      "transaction_type": "S",
      "shares_after_transaction": "5237"
    },
    {
      "id": 118566,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-08-08",
      "transaction_shares": "1304",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "37381"
    },
    {
      "id": 118638,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-08",
      "transaction_shares": "45",
      "transaction_price": "290.18",
      "transaction_type": "S",
      "shares_after_transaction": "5237"
    },
    {
      "id": 8231,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-08-01",
      "transaction_shares": "766",
      "transaction_price": "276.62",
      "transaction_type": "F",
      "shares_after_transaction": "40983"
    },
    {
      "id": 22086,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-08-01",
      "transaction_shares": "766",
      "transaction_price": "276.62",
      "transaction_type": "F",
      "shares_after_transaction": "40983"
    },
    {
      "id": 42934,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-08-01",
      "transaction_shares": "766",
      "transaction_price": "276.62",
      "transaction_type": "F",
      "shares_after_transaction": "40983"
    },
    {
      "id": 76509,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-08-01",
      "transaction_shares": "766",
      "transaction_price": "276.62",
      "transaction_type": "F",
      "shares_after_transaction": "40983"
    },
    {
      "id": 118536,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-08-01",
      "transaction_shares": "766",
      "transaction_price": "276.62",
      "transaction_type": "F",
      "shares_after_transaction": "40983"
    },
    {
      "id": 8232,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-07-29",
      "transaction_shares": "99",
      "transaction_price": "276.65",
      "transaction_type": "S",
      "shares_after_transaction": "5804"
    },
    {
      "id": 22087,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-07-29",
      "transaction_shares": "99",
      "transaction_price": "276.65",
      "transaction_type": "S",
      "shares_after_transaction": "5804"
    },
    {
      "id": 42935,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-07-29",
      "transaction_shares": "99",
      "transaction_price": "276.65",
      "transaction_type": "S",
      "shares_after_transaction": "5804"
    },
    {
      "id": 76510,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-07-29",
      "transaction_shares": "99",
      "transaction_price": "276.65",
      "transaction_type": "S",
      "shares_after_transaction": "5804"
    },
    {
      "id": 118537,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-07-29",
      "transaction_shares": "99",
      "transaction_price": "276.65",
      "transaction_type": "S",
      "shares_after_transaction": "5804"
    },
    {
      "id": 8267,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2022-07-25",
      "transaction_shares": "60342",
      "transaction_price": "91.05",
      "transaction_type": "M",
      "shares_after_transaction": "134502"
    },
    {
      "id": 22130,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2022-07-25",
      "transaction_shares": "60342",
      "transaction_price": "91.05",
      "transaction_type": "M",
      "shares_after_transaction": "134502"
    },
    {
      "id": 43034,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2022-07-25",
      "transaction_shares": "60342",
      "transaction_price": "91.05",
      "transaction_type": "M",
      "shares_after_transaction": "134502"
    },
    {
      "id": 76626,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2022-07-25",
      "transaction_shares": "60342",
      "transaction_price": "91.05",
      "transaction_type": "M",
      "shares_after_transaction": "134502"
    },
    {
      "id": 118667,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2022-07-25",
      "transaction_shares": "60342",
      "transaction_price": "91.05",
      "transaction_type": "M",
      "shares_after_transaction": "134502"
    },
    {
      "id": 8253,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-07-19",
      "transaction_shares": "10427",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "46604"
    },
    {
      "id": 22110,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-07-19",
      "transaction_shares": "10427",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "46604"
    },
    {
      "id": 42988,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-07-19",
      "transaction_shares": "10427",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "46604"
    },
    {
      "id": 76573,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-07-19",
      "transaction_shares": "10427",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "46604"
    },
    {
      "id": 118608,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-07-19",
      "transaction_shares": "10427",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "46604"
    },
    {
      "id": 7,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2022-06-24",
      "transaction_shares": "11689",
      "transaction_price": "291.30",
      "transaction_type": "S",
      "shares_after_transaction": "111153"
    },
    {
      "id": 8239,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2022-06-24",
      "transaction_shares": "11689",
      "transaction_price": "291.30",
      "transaction_type": "S",
      "shares_after_transaction": "111153"
    },
    {
      "id": 22094,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2022-06-24",
      "transaction_shares": "11689",
      "transaction_price": "291.30",
      "transaction_type": "S",
      "shares_after_transaction": "111153"
    },
    {
      "id": 42950,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2022-06-24",
      "transaction_shares": "11689",
      "transaction_price": "291.30",
      "transaction_type": "S",
      "shares_after_transaction": "111153"
    },
    {
      "id": 76526,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2022-06-24",
      "transaction_shares": "11689",
      "transaction_price": "291.30",
      "transaction_type": "S",
      "shares_after_transaction": "111153"
    },
    {
      "id": 118554,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2022-06-24",
      "transaction_shares": "11689",
      "transaction_price": "291.30",
      "transaction_type": "S",
      "shares_after_transaction": "111153"
    },
    {
      "id": 5,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2022-05-31",
      "transaction_shares": "311",
      "transaction_price": "271.24",
      "transaction_type": "F",
      "shares_after_transaction": "49512"
    },
    {
      "id": 8237,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2022-05-31",
      "transaction_shares": "311",
      "transaction_price": "271.24",
      "transaction_type": "F",
      "shares_after_transaction": "49512"
    },
    {
      "id": 22092,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2022-05-31",
      "transaction_shares": "311",
      "transaction_price": "271.24",
      "transaction_type": "F",
      "shares_after_transaction": "49512"
    },
    {
      "id": 42942,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2022-05-31",
      "transaction_shares": "311",
      "transaction_price": "271.24",
      "transaction_type": "F",
      "shares_after_transaction": "49512"
    },
    {
      "id": 76517,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2022-05-31",
      "transaction_shares": "311",
      "transaction_price": "271.24",
      "transaction_type": "F",
      "shares_after_transaction": "49512"
    },
    {
      "id": 118544,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2022-05-31",
      "transaction_shares": "311",
      "transaction_price": "271.24",
      "transaction_type": "F",
      "shares_after_transaction": "49512"
    },
    {
      "id": 3,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-18",
      "transaction_shares": "1558",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "1558"
    },
    {
      "id": 8233,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-18",
      "transaction_shares": "1558",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "1558"
    },
    {
      "id": 22088,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-18",
      "transaction_shares": "1558",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "1558"
    },
    {
      "id": 42936,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-18",
      "transaction_shares": "1558",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "1558"
    },
    {
      "id": 76511,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-18",
      "transaction_shares": "1558",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "1558"
    },
    {
      "id": 118538,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-18",
      "transaction_shares": "1558",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "1558"
    },
    {
      "id": 42958,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP, Chief Patient Officer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1672",
      "transaction_price": "0.00",
      "transaction_type": "G",
      "shares_after_transaction": "11052"
    },
    {
      "id": 76536,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP, Chief Patient Officer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1672",
      "transaction_price": "0.00",
      "transaction_type": "G",
      "shares_after_transaction": "11052"
    },
    {
      "id": 118564,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP, Chief Patient Officer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1672",
      "transaction_price": "0.00",
      "transaction_type": "G",
      "shares_after_transaction": "11052"
    },
    {
      "id": 1,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-16",
      "transaction_shares": "7",
      "transaction_price": "250.56",
      "transaction_type": "S",
      "shares_after_transaction": "41787"
    },
    {
      "id": 6,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-16",
      "transaction_shares": "11",
      "transaction_price": "246.21",
      "transaction_type": "S",
      "shares_after_transaction": "64882"
    },
    {
      "id": 17,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-05-16",
      "transaction_shares": "25",
      "transaction_price": "250.77",
      "transaction_type": "S",
      "shares_after_transaction": "14442"
    },
    {
      "id": 8228,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-16",
      "transaction_shares": "7",
      "transaction_price": "250.56",
      "transaction_type": "S",
      "shares_after_transaction": "41787"
    },
    {
      "id": 8238,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-16",
      "transaction_shares": "11",
      "transaction_price": "246.21",
      "transaction_type": "S",
      "shares_after_transaction": "64882"
    },
    {
      "id": 8254,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-05-16",
      "transaction_shares": "25",
      "transaction_price": "250.77",
      "transaction_type": "S",
      "shares_after_transaction": "14442"
    },
    {
      "id": 22083,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-16",
      "transaction_shares": "7",
      "transaction_price": "250.56",
      "transaction_type": "S",
      "shares_after_transaction": "41787"
    },
    {
      "id": 22093,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-16",
      "transaction_shares": "11",
      "transaction_price": "246.21",
      "transaction_type": "S",
      "shares_after_transaction": "64882"
    },
    {
      "id": 22112,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-05-16",
      "transaction_shares": "25",
      "transaction_price": "250.77",
      "transaction_type": "S",
      "shares_after_transaction": "14442"
    },
    {
      "id": 42928,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-16",
      "transaction_shares": "7",
      "transaction_price": "250.56",
      "transaction_type": "S",
      "shares_after_transaction": "41787"
    },
    {
      "id": 42948,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-16",
      "transaction_shares": "11",
      "transaction_price": "246.21",
      "transaction_type": "S",
      "shares_after_transaction": "64882"
    },
    {
      "id": 42994,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-05-16",
      "transaction_shares": "25",
      "transaction_price": "250.77",
      "transaction_type": "S",
      "shares_after_transaction": "14442"
    },
    {
      "id": 76502,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-16",
      "transaction_shares": "7",
      "transaction_price": "250.56",
      "transaction_type": "S",
      "shares_after_transaction": "41787"
    },
    {
      "id": 76523,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-16",
      "transaction_shares": "11",
      "transaction_price": "246.21",
      "transaction_type": "S",
      "shares_after_transaction": "64882"
    },
    {
      "id": 76580,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-05-16",
      "transaction_shares": "25",
      "transaction_price": "250.77",
      "transaction_type": "S",
      "shares_after_transaction": "14442"
    },
    {
      "id": 118527,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-16",
      "transaction_shares": "7",
      "transaction_price": "250.56",
      "transaction_type": "S",
      "shares_after_transaction": "41787"
    },
    {
      "id": 118551,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-16",
      "transaction_shares": "11",
      "transaction_price": "246.21",
      "transaction_type": "S",
      "shares_after_transaction": "64882"
    },
    {
      "id": 118616,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-05-16",
      "transaction_shares": "25",
      "transaction_price": "250.77",
      "transaction_type": "S",
      "shares_after_transaction": "14442"
    },
    {
      "id": 9,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-04",
      "transaction_shares": "36",
      "transaction_price": "275.09",
      "transaction_type": "S",
      "shares_after_transaction": "41660"
    },
    {
      "id": 8241,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-04",
      "transaction_shares": "36",
      "transaction_price": "275.09",
      "transaction_type": "S",
      "shares_after_transaction": "41660"
    },
    {
      "id": 22096,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-04",
      "transaction_shares": "36",
      "transaction_price": "275.09",
      "transaction_type": "S",
      "shares_after_transaction": "41660"
    },
    {
      "id": 42952,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-04",
      "transaction_shares": "36",
      "transaction_price": "275.09",
      "transaction_type": "S",
      "shares_after_transaction": "41660"
    },
    {
      "id": 76528,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-04",
      "transaction_shares": "36",
      "transaction_price": "275.09",
      "transaction_type": "S",
      "shares_after_transaction": "41660"
    },
    {
      "id": 118556,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-04",
      "transaction_shares": "36",
      "transaction_price": "275.09",
      "transaction_type": "S",
      "shares_after_transaction": "41660"
    },
    {
      "id": 2,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "255.47",
      "transaction_type": "S",
      "shares_after_transaction": "41996"
    },
    {
      "id": 12,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "40",
      "transaction_price": "255.40",
      "transaction_type": "S",
      "shares_after_transaction": "6600"
    },
    {
      "id": 16,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "254.87",
      "transaction_type": "S",
      "shares_after_transaction": "43053"
    },
    {
      "id": 18,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "306",
      "transaction_price": "263.98",
      "transaction_type": "S",
      "shares_after_transaction": "64760"
    },
    {
      "id": 8230,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "255.47",
      "transaction_type": "S",
      "shares_after_transaction": "41996"
    },
    {
      "id": 8246,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "40",
      "transaction_price": "255.40",
      "transaction_type": "S",
      "shares_after_transaction": "6600"
    },
    {
      "id": 8250,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "254.87",
      "transaction_type": "S",
      "shares_after_transaction": "43053"
    },
    {
      "id": 8255,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "306",
      "transaction_price": "263.98",
      "transaction_type": "S",
      "shares_after_transaction": "64760"
    },
    {
      "id": 22085,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "255.47",
      "transaction_type": "S",
      "shares_after_transaction": "41996"
    },
    {
      "id": 22103,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "40",
      "transaction_price": "255.40",
      "transaction_type": "S",
      "shares_after_transaction": "6600"
    },
    {
      "id": 22107,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "254.87",
      "transaction_type": "S",
      "shares_after_transaction": "43053"
    },
    {
      "id": 22114,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "306",
      "transaction_price": "263.98",
      "transaction_type": "S",
      "shares_after_transaction": "64760"
    },
    {
      "id": 42933,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "255.47",
      "transaction_type": "S",
      "shares_after_transaction": "41996"
    },
    {
      "id": 42974,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "40",
      "transaction_price": "255.40",
      "transaction_type": "S",
      "shares_after_transaction": "6600"
    },
    {
      "id": 42985,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "254.87",
      "transaction_type": "S",
      "shares_after_transaction": "43053"
    },
    {
      "id": 42996,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "306",
      "transaction_price": "263.98",
      "transaction_type": "S",
      "shares_after_transaction": "64760"
    },
    {
      "id": 76507,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "255.47",
      "transaction_type": "S",
      "shares_after_transaction": "41996"
    },
    {
      "id": 76555,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "40",
      "transaction_price": "255.40",
      "transaction_type": "S",
      "shares_after_transaction": "6600"
    },
    {
      "id": 76570,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "254.87",
      "transaction_type": "S",
      "shares_after_transaction": "43053"
    },
    {
      "id": 76582,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "306",
      "transaction_price": "263.98",
      "transaction_type": "S",
      "shares_after_transaction": "64760"
    },
    {
      "id": 118533,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "255.47",
      "transaction_type": "S",
      "shares_after_transaction": "41996"
    },
    {
      "id": 118586,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "40",
      "transaction_price": "255.40",
      "transaction_type": "S",
      "shares_after_transaction": "6600"
    },
    {
      "id": 118605,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-05-02",
      "transaction_shares": "20",
      "transaction_price": "254.87",
      "transaction_type": "S",
      "shares_after_transaction": "43053"
    },
    {
      "id": 118618,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "306",
      "transaction_price": "263.98",
      "transaction_type": "S",
      "shares_after_transaction": "64760"
    },
    {
      "id": 4,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6640"
    },
    {
      "id": 8,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6850"
    },
    {
      "id": 21,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kearney Terrence C",
      "reporting_owner_cik": "0001289098",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "725",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6536"
    },
    {
      "id": 25,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1842",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "1435"
    },
    {
      "id": 27,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCGLYNN MARGARET G",
      "reporting_owner_cik": "0001215126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "921",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "178"
    },
    {
      "id": 8235,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6640"
    },
    {
      "id": 8240,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6850"
    },
    {
      "id": 8258,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kearney Terrence C",
      "reporting_owner_cik": "0001289098",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "725",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6536"
    },
    {
      "id": 8270,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1842",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "1435"
    },
    {
      "id": 8272,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCGLYNN MARGARET G",
      "reporting_owner_cik": "0001215126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "921",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "178"
    },
    {
      "id": 22090,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6640"
    },
    {
      "id": 22095,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6850"
    },
    {
      "id": 22117,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kearney Terrence C",
      "reporting_owner_cik": "0001289098",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "725",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6536"
    },
    {
      "id": 22134,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1842",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "1435"
    },
    {
      "id": 22136,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCGLYNN MARGARET G",
      "reporting_owner_cik": "0001215126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "921",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "178"
    },
    {
      "id": 42938,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6640"
    },
    {
      "id": 42951,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6850"
    },
    {
      "id": 43005,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kearney Terrence C",
      "reporting_owner_cik": "0001289098",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "725",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6536"
    },
    {
      "id": 43040,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1842",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "1435"
    },
    {
      "id": 43045,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCGLYNN MARGARET G",
      "reporting_owner_cik": "0001215126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "921",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "178"
    },
    {
      "id": 76513,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6640"
    },
    {
      "id": 76527,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6850"
    },
    {
      "id": 76593,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kearney Terrence C",
      "reporting_owner_cik": "0001289098",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "725",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6536"
    },
    {
      "id": 76633,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1842",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "1435"
    },
    {
      "id": 76638,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCGLYNN MARGARET G",
      "reporting_owner_cik": "0001215126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "921",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "178"
    },
    {
      "id": 118540,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6640"
    },
    {
      "id": 118555,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1449",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6850"
    },
    {
      "id": 118630,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kearney Terrence C",
      "reporting_owner_cik": "0001289098",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "725",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6536"
    },
    {
      "id": 118674,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "1842",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "1435"
    },
    {
      "id": 118680,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCGLYNN MARGARET G",
      "reporting_owner_cik": "0001215126",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-01",
      "transaction_shares": "921",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "178"
    },
    {
      "id": 11,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-04-29",
      "transaction_shares": "17",
      "transaction_price": "273.37",
      "transaction_type": "S",
      "shares_after_transaction": "14437"
    },
    {
      "id": 23,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-04-29",
      "transaction_shares": "547",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "43073"
    },
    {
      "id": 24,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-04-29",
      "transaction_shares": "766",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "42016"
    },
    {
      "id": 8244,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-04-29",
      "transaction_shares": "17",
      "transaction_price": "273.37",
      "transaction_type": "S",
      "shares_after_transaction": "14437"
    },
    {
      "id": 8264,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-04-29",
      "transaction_shares": "547",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "43073"
    },
    {
      "id": 8269,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-04-29",
      "transaction_shares": "766",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "42016"
    },
    {
      "id": 22101,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-04-29",
      "transaction_shares": "17",
      "transaction_price": "273.37",
      "transaction_type": "S",
      "shares_after_transaction": "14437"
    },
    {
      "id": 22127,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-04-29",
      "transaction_shares": "547",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "43073"
    },
    {
      "id": 22133,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-04-29",
      "transaction_shares": "766",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "42016"
    },
    {
      "id": 42967,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-04-29",
      "transaction_shares": "17",
      "transaction_price": "273.37",
      "transaction_type": "S",
      "shares_after_transaction": "14437"
    },
    {
      "id": 43022,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-04-29",
      "transaction_shares": "547",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "43073"
    },
    {
      "id": 43037,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-04-29",
      "transaction_shares": "766",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "42016"
    },
    {
      "id": 76548,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-04-29",
      "transaction_shares": "17",
      "transaction_price": "273.37",
      "transaction_type": "S",
      "shares_after_transaction": "14437"
    },
    {
      "id": 76613,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-04-29",
      "transaction_shares": "547",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "43073"
    },
    {
      "id": 76630,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-04-29",
      "transaction_shares": "766",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "42016"
    },
    {
      "id": 118579,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-04-29",
      "transaction_shares": "17",
      "transaction_price": "273.37",
      "transaction_type": "S",
      "shares_after_transaction": "14437"
    },
    {
      "id": 118652,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2022-04-29",
      "transaction_shares": "547",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "43073"
    },
    {
      "id": 118671,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-04-29",
      "transaction_shares": "766",
      "transaction_price": "276.17",
      "transaction_type": "F",
      "shares_after_transaction": "42016"
    },
    {
      "id": 15,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2022-04-25",
      "transaction_shares": "60",
      "transaction_price": "267.37",
      "transaction_type": "S",
      "shares_after_transaction": "3763"
    },
    {
      "id": 8249,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2022-04-25",
      "transaction_shares": "60",
      "transaction_price": "267.37",
      "transaction_type": "S",
      "shares_after_transaction": "3763"
    },
    {
      "id": 22106,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2022-04-25",
      "transaction_shares": "60",
      "transaction_price": "267.37",
      "transaction_type": "S",
      "shares_after_transaction": "3763"
    },
    {
      "id": 42983,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2022-04-25",
      "transaction_shares": "60",
      "transaction_price": "267.37",
      "transaction_type": "S",
      "shares_after_transaction": "3763"
    },
    {
      "id": 76568,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2022-04-25",
      "transaction_shares": "60",
      "transaction_price": "267.37",
      "transaction_type": "S",
      "shares_after_transaction": "3763"
    },
    {
      "id": 118603,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2022-04-25",
      "transaction_shares": "60",
      "transaction_price": "267.37",
      "transaction_type": "S",
      "shares_after_transaction": "3763"
    },
    {
      "id": 10,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-18",
      "transaction_shares": "2000",
      "transaction_price": "81.54",
      "transaction_type": "M",
      "shares_after_transaction": "3875"
    },
    {
      "id": 8243,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-18",
      "transaction_shares": "2000",
      "transaction_price": "81.54",
      "transaction_type": "M",
      "shares_after_transaction": "3875"
    },
    {
      "id": 22100,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-18",
      "transaction_shares": "2000",
      "transaction_price": "81.54",
      "transaction_type": "M",
      "shares_after_transaction": "3875"
    },
    {
      "id": 42963,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-18",
      "transaction_shares": "2000",
      "transaction_price": "81.54",
      "transaction_type": "M",
      "shares_after_transaction": "3875"
    },
    {
      "id": 76543,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-18",
      "transaction_shares": "2000",
      "transaction_price": "81.54",
      "transaction_type": "M",
      "shares_after_transaction": "3875"
    },
    {
      "id": 118574,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lee Yuchun",
      "reporting_owner_cik": "0001334365",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-18",
      "transaction_shares": "2000",
      "transaction_price": "81.54",
      "transaction_type": "M",
      "shares_after_transaction": "3875"
    }
  ]
}